Rugiet is a men's health platform offering personalized hormone care for issues like low energy and mood changes. The platform provides two main treatments: enclomiphene to boost natural testosterone ...
New platform connects patients with licensed providers offering sermorelin under medical supervision, supported by a growing body of peer-reviewed research and an emerging community of clinicians and ...
Morning Overview on MSN
Single intramuscular shot shows promise for faster heart attack recovery
A single intramuscular injection of a self-amplifying RNA therapy produced weeks of heart-protective protein in rat models of myocardial infarction, according to a study published in Science on March ...
Novo Nordisk A/S (NYSE:NVO) was upgraded to Equal Weight from Underweight by Morgan Stanley on March 3. The firm also adjusted the price target on the stock to $40 from $42, stati ...
Peptide stacking, the latest injectable wellness trend, promises multiple results at once, but is it backed by science? We asked top experts for their thoughts.
Twenty camels have been disqualified from a major beauty contest in Oman after veterinarians discovered signs of cosmetic ...
HSS Presents New Findings Impacting Pediatric Orthopedic Care Recommendations at AAOS Annual Meeting
At this year's American Academy of Orthopedic Surgeons (AAOS) annual meeting, investigators at Hospital for Special Surgery (HSS) presented several significant studies, two of which could lead to ...
Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...
FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
"Daily injections have defined the growth disorder treatment paradigm for more than 40 years. Our scientific leadership and focus on advancing care in rare diseases led us to the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results